Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Halank

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|August 24, 2004
[Treatment of severe pneumonia--community-acquired and "early onset" nosocomial]Gert Höffken, Michael Halank, Adrian Gillissen
Treatments in Respiratory Medicine|August 10, 2005
Short-course antimicrobial therapy for community-acquired pneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Treatments in Respiratory Medicine|December 13, 2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired PneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Journal of Gastroenterology|December 29, 2004
Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertensionMichael Halank, Christian Marx, Stephan Miehlke, et al.
BMC Neurology|June 8, 2014
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery diseaseKatja Thomas, Hagen Schrötter, Michael Halank, et al.
Journal of Gastroenterology|October 19, 2006
Portopulmonary hypertensionMichael Halank, Ralf Ewert, Hans-Juergen Seyfarth, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitisDirk Steffen Koschel, Martin Kolditz, Gert Höeffken, et al.
American Journal of Respiratory and Critical Care Medicine|December 4, 2012
A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapyRalf Ewert, Michael Halank, Leonhard Bruch, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertensionMichael Halank, Martin Kolditz, Christian Opitz, et al.
Lung|January 20, 2012
Pulmonary hypertension in chronic hypersensitivity pneumonitisDirk S Koschel, Carlos Cardoso, Bärbel Wiedemann, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Medizinische Klinik (Munich, Germany : 1983)|August 24, 2004
[Treatment of severe pneumonia--community-acquired and "early onset" nosocomial]Gert Höffken, Michael Halank, Adrian Gillissen
Treatments in Respiratory Medicine|August 10, 2005
Short-course antimicrobial therapy for community-acquired pneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Treatments in Respiratory Medicine|December 13, 2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired PneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Journal of Gastroenterology|December 29, 2004
Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertensionMichael Halank, Christian Marx, Stephan Miehlke, et al.
BMC Neurology|June 8, 2014
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery diseaseKatja Thomas, Hagen Schrötter, Michael Halank, et al.
Journal of Gastroenterology|October 19, 2006
Portopulmonary hypertensionMichael Halank, Ralf Ewert, Hans-Juergen Seyfarth, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitisDirk Steffen Koschel, Martin Kolditz, Gert Höeffken, et al.
American Journal of Respiratory and Critical Care Medicine|December 4, 2012
A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapyRalf Ewert, Michael Halank, Leonhard Bruch, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertensionMichael Halank, Martin Kolditz, Christian Opitz, et al.
Lung|January 20, 2012
Pulmonary hypertension in chronic hypersensitivity pneumonitisDirk S Koschel, Carlos Cardoso, Bärbel Wiedemann, et al.
Pageof 14